Protara Therapeutics, Inc. Investment Income, Net
Protara Therapeutics, Inc. (TARA) reported Investment Income, Net of $687.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2023-05-04
- Protara Therapeutics, Inc. investment income, net for the quarter ending 2023-03-31 was $687.00K, a 477.31% increase year-over-year.
- Protara Therapeutics, Inc. investment income, net for the quarter ending 2022-12-31 was $542.00K, a 818.64% increase year-over-year.
- Protara Therapeutics, Inc. investment income, net for the quarter ending 2022-09-30 was $283.00K, a 433.96% increase year-over-year.
- Protara Therapeutics, Inc. investment income, net for the quarter ending 2022-06-30 was $166.00K, a 1560.00% increase year-over-year.
- Protara Therapeutics, Inc. investment income, net for fiscal 2022 was $1.11M, a 368.35% increase from fiscal 2021.
- Protara Therapeutics, Inc. investment income, net for fiscal 2021 was $237.00K, a 52.60% decline from fiscal 2020.
- Protara Therapeutics, Inc. investment income, net for fiscal 2020 was $500.00K, a 90.84% increase from fiscal 2019.
- Protara Therapeutics, Inc. investment income, net for fiscal 2019 was $262.00K, a 39.91% decline from fiscal 2018.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2023-03-31 | $687.00K 10-Q · filed 2023-05-04 | $1.23M derived: sum of 2 quarters · filed 2023-05-04 | $1.51M derived: sum of 3 quarters · filed 2023-05-04 | $1.68M derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | $542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $825.00K derived: sum of 2 quarters · filed 2023-03-08 | $991.00K derived: sum of 3 quarters · filed 2023-03-08 | $1.11M 10-K · filed 2023-03-08 |
| 2022-09-30 | $283.00K 10-Q · filed 2022-11-03 | $449.00K derived: sum of 2 quarters · filed 2022-11-03 | $568.00K 10-Q · filed 2022-11-03 | $627.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-06-30 | $166.00K 10-Q · filed 2022-08-09 | $285.00K 10-Q · filed 2022-08-09 | $344.00K derived: sum of 3 quarters · filed 2023-05-04 | $397.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-03-31 | $119.00K 10-Q · filed 2023-05-04 | $178.00K derived: sum of 2 quarters · filed 2023-05-04 | $231.00K derived: sum of 3 quarters · filed 2023-05-04 | $241.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $112.00K derived: sum of 2 quarters · filed 2023-03-08 | $122.00K derived: sum of 3 quarters · filed 2023-03-08 | $237.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $53.00K 10-Q · filed 2022-11-03 | $63.00K derived: sum of 2 quarters · filed 2022-11-03 | $178.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $10.00K 10-Q · filed 2022-08-09 | $125.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $115.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $500.00K 10-K · filed 2022-03-09 | |||
| 2019-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $84.00K derived: sum of 2 quarters · filed 2020-03-20 | $157.00K derived: sum of 3 quarters · filed 2020-03-20 | $262.00K 10-K · filed 2020-03-20 |
| 2019-09-30 | $53.00K 10-Q · filed 2019-10-31 | $126.00K derived: sum of 2 quarters · filed 2019-10-31 | $231.00K 10-Q · filed 2019-10-31 | $356.00K derived: sum of 4 quarters · filed 2020-03-20 |
| 2019-06-30 | $73.00K 10-Q · filed 2019-08-07 | $178.00K 10-Q · filed 2019-08-07 | $303.00K derived: sum of 3 quarters · filed 2020-03-20 | $416.00K derived: sum of 4 quarters · filed 2020-03-20 |
| 2019-03-31 | $105.00K 10-Q · filed 2019-05-08 | $230.00K derived: sum of 2 quarters · filed 2020-03-20 | $343.00K derived: sum of 3 quarters · filed 2020-03-20 | $449.00K derived: sum of 4 quarters · filed 2020-03-20 |
| 2018-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $238.00K derived: sum of 2 quarters · filed 2020-03-20 | $344.00K derived: sum of 3 quarters · filed 2020-03-20 | $436.00K 10-K · filed 2020-03-20 |
| 2018-09-30 | $113.00K 10-Q · filed 2019-10-31 | $219.00K derived: sum of 2 quarters · filed 2019-10-31 | $311.00K 10-Q · filed 2019-10-31 | $409.00K derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $106.00K 10-Q · filed 2019-08-07 | $198.00K 10-Q · filed 2019-08-07 | $296.00K derived: sum of 3 quarters · filed 2019-08-07 | $379.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $92.00K 10-Q · filed 2019-05-08 | $190.00K derived: sum of 2 quarters · filed 2019-05-08 | $273.00K derived: sum of 3 quarters · filed 2019-05-08 | $319.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $181.00K derived: sum of 2 quarters · filed 2019-03-13 | $227.00K derived: sum of 3 quarters · filed 2019-03-13 | $259.00K 10-K · filed 2019-03-13 |
| 2017-09-30 | $83.00K 10-Q · filed 2018-11-07 | $129.00K derived: sum of 2 quarters · filed 2018-11-07 | $161.00K 10-Q · filed 2018-11-07 | $199.00K derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-06-30 | $46.00K 10-Q · filed 2018-08-07 | $78.00K 10-Q · filed 2018-08-07 | $116.00K derived: sum of 3 quarters · filed 2019-03-13 | $162.00K derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-03-31 | $32.00K 10-Q · filed 2018-05-09 | $70.00K derived: sum of 2 quarters · filed 2019-03-13 | $116.00K derived: sum of 3 quarters · filed 2019-03-13 | $169.00K derived: sum of 4 quarters · filed 2019-03-13 |
| 2016-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $84.00K derived: sum of 2 quarters · filed 2019-03-13 | $137.00K derived: sum of 3 quarters · filed 2019-03-13 | $193.00K 10-K · filed 2019-03-13 |
| 2016-09-30 | $46.00K 10-Q · filed 2017-11-07 | $99.00K derived: sum of 2 quarters · filed 2017-11-07 | $155.00K 10-Q · filed 2017-11-07 | $188.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $53.00K 10-Q · filed 2017-08-07 | $109.00K 10-Q · filed 2017-08-07 | $142.00K derived: sum of 3 quarters · filed 2018-03-14 | $176.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $56.00K 10-Q · filed 2017-05-10 | $89.00K derived: sum of 2 quarters · filed 2018-03-14 | $123.00K derived: sum of 3 quarters · filed 2018-03-14 | $160.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $67.00K derived: sum of 2 quarters · filed 2018-03-14 | $104.00K derived: sum of 3 quarters · filed 2018-03-14 | $144.00K 10-K · filed 2018-03-14 |
| 2015-09-30 | $34.00K 10-Q · filed 2016-11-07 | $71.00K derived: sum of 2 quarters · filed 2016-11-07 | $111.00K 10-Q · filed 2016-11-07 | $122.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $37.00K 10-Q · filed 2016-08-08 | $77.00K 10-Q · filed 2016-08-08 | $88.00K derived: sum of 3 quarters · filed 2017-03-16 | $98.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $40.00K 10-Q · filed 2016-05-09 | $51.00K derived: sum of 2 quarters · filed 2017-03-16 | $61.00K derived: sum of 3 quarters · filed 2017-03-16 | $64.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $21.00K derived: sum of 2 quarters · filed 2017-03-16 | $24.00K derived: sum of 3 quarters · filed 2017-03-16 | $24.00K 10-K · filed 2017-03-16 |
| 2014-09-30 | $10.00K 10-Q · filed 2015-11-12 | $13.00K derived: sum of 2 quarters · filed 2015-11-12 | $13.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $3.00K 10-Q · filed 2015-08-13 | $3.00K 10-Q · filed 2015-08-13 | ||
| 2013-12-31 | $4.00K 10-K · filed 2016-03-14 | |||
| 2012-12-31 | $20.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |